MedMira Reports Second Quarter Results FY2025

  • HALIFAX, NS / ACCESS Newswire / June 30, 2025 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2025. Corporate update In Q3 FY2025, MedMira launched its recently Health Canada approved Multiplo\u00ae Rapid TP/HIV Test (Multiplo\u00ae TP/HIV) and its latest generation of its Reveal\u00ae Rapid HIV Test in Canada through its partner Trimedic.